Get the app
USHealthcare

Pro-Dex Inc (PDEX)

US · Healthcare · Medical Instruments & Supplies

$69.47-3.31%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$20.4M
Revenue YoY
+16.6%
Net profit
$2.9M
Profit YoY
+138.9%
EPS
$0.87
EPS estimate
$0.67
Net margin
14.0%

EPS came in at 0.87 against a street estimate of 0.67 — a beat of 29.9%.

Key statistics

Market cap
$201.2M
P/E
14.6
Forward P/E
24.0
P/B
4.05
Book value
$14.95
EPS (TTM)
$4.30
52-week high
$77.00
52-week low
$23.47
50-day MA
$62.18
200-day MA
$52.06
Beta
0.06

Analyst view

Analysts rate Pro-Dex Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $70.00.

Shareholding

Insiders
36.96%
Institutions
31.72%

Largest institutional holders

FundStake
BlackRock Inc4.78%
Vanguard Capital Management, LLC3.49%
Dimensional Fund Advisors, Inc.1.79%
Punch & Associates Inv Mgmt Inc1.65%
Geode Capital Management, LLC1.51%
Northern Trust Corp1.46%
State Street Corp1.04%
JPMorgan Chase & Co1.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pro-Dex Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.